Last updated: April 19, 2026

Application No. 18/583,667

COMPOSITIONS AND METHODS

Final Rejection

Filed

Feb 21, 2024

Examiner

DEVI, SARVAMANGALA

Art Unit

1645

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Seres Therapeutics Inc.

OA Round

2 (Final)

Interview Optional

— +54.4% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 859 resolved cases, 2023–2026

Examiner Intelligence

DEVI, SARVAMANGALA View full profile →

Grants 66% — above average

Career Allow Rate

568 granted / 859 resolved

+6.1% vs TC avg

Strong +54% interview lift

Without

With

+54.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

51 currently pending

Career history

910

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

19.1%

-20.9% vs TC avg

§102

17.0%

-23.0% vs TC avg

§112

17.7%

-22.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 859 resolved cases

Prosecution Timeline

Feb 21, 2024

Application Filed

Mar 08, 2025

Non-Final Rejection

Jul 14, 2025

Response Filed

Nov 01, 2025

Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/323,235

Patent 12594311

LACTOBACILLUS PLANTARUM PDG8 AND USE IN TREATING CARDIOVASCULAR DISEASES

2y 5m to grant Granted Apr 07, 2026

18/641,696

Patent 12569521

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS

2y 5m to grant Granted Mar 10, 2026

17/799,340

Patent 12495801

BACILLUS SUBTILIS JCK-1398 STRAIN INDUCING RESISTANCE IN VARIOUS PLANTS, AND COMPOSITION AND METHOD FOR CONTROLLING PINE WILT DISEASE BY USING SAME

2y 5m to grant Granted Dec 16, 2025

18/329,701

Patent 12485164

MENINGOCOCCUS VACCINES

2y 5m to grant Granted Dec 02, 2025

18/334,392

Patent 12472139

METHOD FOR MAINTAINING SKIN CORNEUM LAYER COMPLETENESS, PROMOTING HYALURONIC ACID PRODUCTION, IMPROVING SKIN CELL MITOCHONDRION ACTIVITY AND/ OR PROMOTING SKIN CELL PROLIFERATION BY USING BACTERIAL LYSATE OF HALOBACILLUS TRUEPERI TCI66207

2y 5m to grant Granted Nov 18, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

3-4

Expected OA Rounds

66%

Grant Probability

99%

With Interview (+54.4%)

3y 4m

Median Time to Grant

Moderate

PTA Risk

Based on 859 resolved cases by this examiner. Grant probability derived from career allow rate.